Feng Li

Company: Harbour BioMed

Job title: Director

Seminars:

Panel Discussion: Streamlining Regulatory Approaches to Optimize CDx Development, Reduce Complexities & Allow Patients Timely Access to Drug-Diagnostics Clinical Trials 9:30 am

Given the fragmentation of regulatory requirements, will it be more beneficial to stakeholders to harmonise across APAC or will this create friction? Is there a future for there to be one solution that covers all regions to increase harmonisation and enable broader knowledge sharing between countries? Understanding different registration requirements across the region to increase…Read more

day: Conference Day 2

Uncovering Biomarkers to Define Patient Populations 4:45 pm

Significance of biomarkers and CDx that enable precise patient selection and improves therapeutic outcomes Addressing and overcoming challenges and possible solutions in their developmentRead more

day: Conference Day 2